1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 THR B 27 - PRO B 28 MODEL 1 OMEGA = 41.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION THR B 27 - PRO B 28 MODEL 3 OMEGA = 214.06 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION THR B 27 - PRO B 28 MODEL 4 OMEGA = 213.37 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION THR B 27 - PRO B 28 MODEL 8 OMEGA = 216.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION THR B 27 - PRO B 28 MODEL 10 OMEGA = 241.03 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION THR B 27 - PRO B 28 MODEL 11 OMEGA = 217.65 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION THR B 27 - PRO B 28 MODEL 13 OMEGA = 233.42 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION CIS PROLINE - PRO B 28 MODEL 15 THR B 27 - PRO B 28 MODEL 19 OMEGA = 240.85 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION THR B 27 - PRO B 28 MODEL 20 OMEGA = 91.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION Jorgensen, A.M.M. Kristensen, S.M. Led, J.J. Balschmidt, P. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 227 1146 1163 10.1016/0022-2836(92)90527-Q 1433291 Three-dimensional solution structure of an insulin dimer. A study of the B9(Asp) mutant of human insulin using nuclear magnetic resonance, distance geometry and restrained molecular dynamics. 1992 UK Magn.Reson.Chem. MRCHEG 0731 0749-1581 33 461 A Carbon-13 NMR Study of the B9(Asp) Mutant of Human Insulin 1995 US Biochemistry BICHAW 0033 0006-2960 33 13727 Structural Details of Asp(B9) Human Insulin at Low Ph from 2D NMR Titration Studies 1994 US J.Am.Chem.Soc. JACSAT 0004 0002-7863 116 747 A New Linear Prediction Model Method for the Determination of Slow Amide Proton Exchange Rates from a Series of One-Dimensional 1H NMR Spectra 1994 US J.Am.Chem.Soc. JACSAT 0004 0002-7863 115 1457 Slow Amide Proton Exchange Rates from the Line Widths in a Single Two-Dimensional 1H NMR Spectrum 1993 UK J.Mol.Biol. JMOBAK 0070 0022-2836 218 221 Proton Nuclear Magnetic Resonance Study of the B9(Asp) Mutant of Human Insulin. Sequential Assignment and Secondary Structure 1991 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 2383.698 INSULIN S(B 9)D 1 man polymer 3461.963 INSULIN S(B 9)D 1 man polymer no no GIVEQCCTSICSLYQLENYCN GIVEQCCTSICSLYQLENYCN A polypeptide(L) no no FVNQHLCGDHLVEALYLVCGERGFFYTPKT FVNQHLCGDHLVEALYLVCGERGFFYTPKT B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo baker's yeast Saccharomyces sample 9606 Homo sapiens 4932 Saccharomyces cerevisiae human Homo baker's yeast Saccharomyces sample 9606 Homo sapiens 4932 Saccharomyces cerevisiae pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_conf struct_conf_type repository Initial release Version format compliance Version format compliance Derived calculations Other 1 0 1995-10-15 1 1 2008-03-24 1 2 2011-07-13 1 3 2017-11-29 _pdbx_database_status.process_site Y BNL 1994-11-30 REL REL 20 HAVEL,WUTHRICH refinement DISGEO BRUNGER refinement X-PLOR 2.1 GLY 1 n 1 GLY 1 A ILE 2 n 2 ILE 2 A VAL 3 n 3 VAL 3 A GLU 4 n 4 GLU 4 A GLN 5 n 5 GLN 5 A CYS 6 n 6 CYS 6 A CYS 7 n 7 CYS 7 A THR 8 n 8 THR 8 A SER 9 n 9 SER 9 A ILE 10 n 10 ILE 10 A CYS 11 n 11 CYS 11 A SER 12 n 12 SER 12 A LEU 13 n 13 LEU 13 A TYR 14 n 14 TYR 14 A GLN 15 n 15 GLN 15 A LEU 16 n 16 LEU 16 A GLU 17 n 17 GLU 17 A ASN 18 n 18 ASN 18 A TYR 19 n 19 TYR 19 A CYS 20 n 20 CYS 20 A ASN 21 n 21 ASN 21 A PHE 1 n 1 PHE 1 B VAL 2 n 2 VAL 2 B ASN 3 n 3 ASN 3 B GLN 4 n 4 GLN 4 B HIS 5 n 5 HIS 5 B LEU 6 n 6 LEU 6 B CYS 7 n 7 CYS 7 B GLY 8 n 8 GLY 8 B ASP 9 n 9 ASP 9 B HIS 10 n 10 HIS 10 B LEU 11 n 11 LEU 11 B VAL 12 n 12 VAL 12 B GLU 13 n 13 GLU 13 B ALA 14 n 14 ALA 14 B LEU 15 n 15 LEU 15 B TYR 16 n 16 TYR 16 B LEU 17 n 17 LEU 17 B VAL 18 n 18 VAL 18 B CYS 19 n 19 CYS 19 B GLY 20 n 20 GLY 20 B GLU 21 n 21 GLU 21 B ARG 22 n 22 ARG 22 B GLY 23 n 23 GLY 23 B PHE 24 n 24 PHE 24 B PHE 25 n 25 PHE 25 B TYR 26 n 26 TYR 26 B THR 27 n 27 THR 27 B PRO 28 n 28 PRO 28 B LYS 29 n 29 LYS 29 B THR 30 n 30 THR 30 B author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 B B THR PRO 27 28 41.00 3 B B THR PRO 27 28 -145.94 4 B B THR PRO 27 28 -146.63 8 B B THR PRO 27 28 -143.76 10 B B THR PRO 27 28 -118.97 11 B B THR PRO 27 28 -142.35 13 B B THR PRO 27 28 -126.58 19 B B THR PRO 27 28 -119.15 20 B B THR PRO 27 28 91.63 1 B ARG 22 0.111 SIDE CHAIN 2 B ARG 22 0.292 SIDE CHAIN 3 B ARG 22 0.296 SIDE CHAIN 4 B ARG 22 0.166 SIDE CHAIN 5 B ARG 22 0.285 SIDE CHAIN 6 B ARG 22 0.279 SIDE CHAIN 7 B ARG 22 0.212 SIDE CHAIN 8 B ARG 22 0.289 SIDE CHAIN 9 B ARG 22 0.277 SIDE CHAIN 10 B ARG 22 0.286 SIDE CHAIN 11 B ARG 22 0.142 SIDE CHAIN 12 B ARG 22 0.327 SIDE CHAIN 13 B ARG 22 0.211 SIDE CHAIN 14 B ARG 22 0.294 SIDE CHAIN 15 B ARG 22 0.299 SIDE CHAIN 16 B ARG 22 0.267 SIDE CHAIN 17 B ARG 22 0.195 SIDE CHAIN 18 B ARG 22 0.305 SIDE CHAIN 19 B ARG 22 0.305 SIDE CHAIN 20 B ARG 22 0.310 SIDE CHAIN 1 7.19 1.10 114.20 121.39 A A A CA CB SG CYS CYS CYS 11 11 11 N 2 7.72 1.10 114.20 121.92 B B B CA CB SG CYS CYS CYS 19 19 19 N 2 19.02 2.70 111.00 130.02 B B B N CA C CYS CYS CYS 19 19 19 N 3 -8.05 0.50 120.30 112.25 B B B NE CZ NH1 ARG ARG ARG 22 22 22 N 3 4.43 0.50 120.30 124.73 B B B NE CZ NH2 ARG ARG ARG 22 22 22 N 3 -17.23 2.10 128.40 111.17 B B B C N CD THR PRO PRO 27 28 28 Y 4 8.89 1.10 114.20 123.09 A A A CA CB SG CYS CYS CYS 11 11 11 N 4 15.00 2.00 110.40 125.40 B B B CB CA C GLU GLU GLU 21 21 21 N 4 -12.41 1.80 110.60 98.19 B B B N CA CB GLU GLU GLU 21 21 21 N 4 -17.34 2.20 117.20 99.86 B B B CA C N GLU GLU ARG 21 21 22 Y 5 19.25 2.70 111.00 130.25 A A A N CA C SER SER SER 12 12 12 N 5 -14.70 2.20 117.20 102.50 B B B CA C N GLU GLU ARG 21 21 22 Y 5 -5.16 0.50 120.30 115.14 B B B NE CZ NH2 ARG ARG ARG 22 22 22 N 6 6.87 1.10 114.20 121.07 A A A CA CB SG CYS CYS CYS 6 6 6 N 6 -14.31 2.30 110.00 95.69 A A A OG1 CB CG2 THR THR THR 8 8 8 N 6 7.35 1.20 111.50 118.85 A A A CB CA C CYS CYS CYS 20 20 20 N 6 -10.88 1.80 110.60 99.72 A A A N CA CB CYS CYS CYS 20 20 20 N 6 6.93 1.10 114.20 121.13 A A A CA CB SG CYS CYS CYS 20 20 20 N 6 -10.99 1.80 110.60 99.61 B B B N CA CB ASP ASP ASP 9 9 9 N 6 -5.26 0.50 120.30 115.04 B B B NE CZ NH2 ARG ARG ARG 22 22 22 N 7 7.65 1.10 114.20 121.85 B B B CA CB SG CYS CYS CYS 19 19 19 N 8 -15.40 2.20 113.40 98.00 A A A CA CB CG GLU GLU GLU 17 17 17 N 8 -13.51 2.20 117.20 103.69 B B B CA C N GLU GLU ARG 21 21 22 Y 8 17.44 2.70 111.00 128.44 B B B N CA C ARG ARG ARG 22 22 22 N 8 -17.13 2.10 128.40 111.27 B B B C N CD THR PRO PRO 27 28 28 Y 9 7.16 1.10 114.20 121.36 A A A CA CB SG CYS CYS CYS 11 11 11 N 10 9.69 1.10 114.20 123.89 A A A CA CB SG CYS CYS CYS 11 11 11 N 10 18.22 2.70 111.00 129.22 A A A N CA C SER SER SER 12 12 12 N 10 -3.85 0.60 121.00 117.15 B B B CB CG CD2 TYR TYR TYR 16 16 16 N 10 11.28 1.10 114.20 125.48 B B B CA CB SG CYS CYS CYS 19 19 19 N 10 17.73 2.70 111.00 128.73 B B B N CA C PHE PHE PHE 24 24 24 N 10 -17.24 2.10 128.40 111.16 B B B C N CD THR PRO PRO 27 28 28 Y 11 23.11 2.70 111.00 134.11 A A A N CA C SER SER SER 12 12 12 N 11 -10.49 1.70 113.60 103.11 B B B CA CB CG HIS HIS HIS 5 5 5 N 11 -4.95 0.60 121.00 116.05 B B B CB CG CD2 TYR TYR TYR 16 16 16 N 11 3.70 0.60 121.00 124.70 B B B CB CG CD1 TYR TYR TYR 16 16 16 N 11 -3.70 0.50 120.30 116.60 B B B NE CZ NH2 ARG ARG ARG 22 22 22 N 11 17.37 2.70 111.00 128.37 B B B N CA C ARG ARG ARG 22 22 22 N 11 -16.09 2.10 128.40 112.31 B B B C N CD THR PRO PRO 27 28 28 Y 12 6.82 1.10 114.20 121.02 A A A CA CB SG CYS CYS CYS 11 11 11 N 12 8.14 1.20 123.30 131.44 A A A OE1 CD OE2 GLU GLU GLU 17 17 17 N 12 -12.87 1.80 110.60 97.73 A A A N CA CB ASN ASN ASN 18 18 18 N 12 -3.87 0.60 121.00 117.13 B B B CB CG CD2 TYR TYR TYR 16 16 16 N 12 -3.13 0.50 120.30 117.17 B B B NE CZ NH1 ARG ARG ARG 22 22 22 N 13 18.66 2.70 111.00 129.66 A A A N CA C ILE ILE ILE 10 10 10 N 13 -3.28 0.50 120.30 117.02 B B B NE CZ NH2 ARG ARG ARG 22 22 22 N 13 -15.80 2.10 128.40 112.60 B B B C N CD THR PRO PRO 27 28 28 Y 14 6.96 1.10 114.20 121.16 A A A CA CB SG CYS CYS CYS 6 6 6 N 14 -4.09 0.50 120.30 116.21 B B B NE CZ NH1 ARG ARG ARG 22 22 22 N 14 -18.08 2.10 128.40 110.32 B B B C N CD THR PRO PRO 27 28 28 Y 15 -16.05 2.30 110.00 93.95 A A A OG1 CB CG2 THR THR THR 8 8 8 N 15 -12.03 1.90 113.40 101.37 A A A CA CB CG TYR TYR TYR 19 19 19 N 15 -4.97 0.60 121.00 116.03 B B B CB CG CD2 TYR TYR TYR 16 16 16 N 15 4.41 0.60 121.00 125.41 B B B CB CG CD1 TYR TYR TYR 16 16 16 N 15 -13.61 1.80 110.60 96.99 B B B N CA CB ARG ARG ARG 22 22 22 N 15 -4.00 0.50 120.30 116.30 B B B NE CZ NH1 ARG ARG ARG 22 22 22 N 15 23.19 2.70 111.00 134.19 B B B N CA C ARG ARG ARG 22 22 22 N 15 -13.07 2.00 116.20 103.13 B B B CA C N ARG ARG GLY 22 22 23 Y 16 -14.11 2.20 111.50 97.39 A A A N CA CB VAL VAL VAL 3 3 3 N 16 -11.57 1.80 110.60 99.03 A A A N CA CB CYS CYS CYS 11 11 11 N 16 12.67 1.10 114.20 126.87 A A A CA CB SG CYS CYS CYS 11 11 11 N 16 21.94 2.70 111.00 132.94 A A A N CA C SER SER SER 12 12 12 N 17 8.71 1.10 114.20 122.91 A A A CA CB SG CYS CYS CYS 11 11 11 N 17 19.70 2.70 111.00 130.70 A A A N CA C SER SER SER 12 12 12 N 17 -4.54 0.60 121.00 116.46 B B B CB CG CD2 TYR TYR TYR 16 16 16 N 17 3.66 0.60 121.00 124.66 B B B CB CG CD1 TYR TYR TYR 16 16 16 N 17 8.55 1.10 114.20 122.75 B B B CA CB SG CYS CYS CYS 19 19 19 N 17 -16.14 2.20 117.20 101.06 B B B CA C N GLU GLU ARG 21 21 22 Y 17 15.73 2.50 121.70 137.43 B B B C N CA GLU ARG ARG 21 22 22 Y 17 -11.79 1.80 110.60 98.81 B B B N CA CB ARG ARG ARG 22 22 22 N 17 -4.80 0.50 120.30 115.50 B B B NE CZ NH2 ARG ARG ARG 22 22 22 N 17 25.27 2.70 111.00 136.27 B B B N CA C ARG ARG ARG 22 22 22 N 17 -15.55 2.10 128.40 112.85 B B B C N CD THR PRO PRO 27 28 28 Y 18 7.84 1.20 111.50 119.34 A A A CB CA C CYS CYS CYS 7 7 7 N 18 -12.33 1.80 110.60 98.27 A A A N CA CB CYS CYS CYS 7 7 7 N 19 9.31 1.10 114.20 123.51 B B B CA CB SG CYS CYS CYS 19 19 19 N 19 -15.30 2.10 128.40 113.10 B B B C N CD THR PRO PRO 27 28 28 Y 1 B B CZ NH1 ARG ARG 22 22 -0.084 0.013 1.326 1.242 N 1 B B CZ NH2 ARG ARG 22 22 -0.086 0.013 1.326 1.240 N 2 B B CZ NH2 ARG ARG 22 22 -0.084 0.013 1.326 1.242 N 3 B B CG ND1 HIS HIS 5 5 -0.093 0.015 1.369 1.276 N 3 B B CZ NH1 ARG ARG 22 22 -0.093 0.013 1.326 1.233 N 4 B B CB CG GLU GLU 21 21 0.161 0.019 1.517 1.678 N 5 B B CG ND1 HIS HIS 5 5 -0.093 0.015 1.369 1.276 N 5 B B CZ NH1 ARG ARG 22 22 -0.078 0.013 1.326 1.248 N 5 B B CZ NH2 ARG ARG 22 22 -0.085 0.013 1.326 1.241 N 6 B B CZ NH2 ARG ARG 22 22 -0.083 0.013 1.326 1.243 N 9 B B CZ NH1 ARG ARG 22 22 -0.083 0.013 1.326 1.243 N 9 B B CZ NH2 ARG ARG 22 22 -0.080 0.013 1.326 1.246 N 10 B B CZ NH1 ARG ARG 22 22 -0.081 0.013 1.326 1.245 N 10 B B CZ NH2 ARG ARG 22 22 -0.083 0.013 1.326 1.243 N 11 B B CG ND1 HIS HIS 5 5 -0.096 0.015 1.369 1.273 N 11 B B CZ NH2 ARG ARG 22 22 -0.081 0.013 1.326 1.245 N 12 B B CZ NH1 ARG ARG 22 22 -0.083 0.013 1.326 1.243 N 12 B B CZ NH2 ARG ARG 22 22 -0.082 0.013 1.326 1.244 N 13 B B CZ NH2 ARG ARG 22 22 -0.079 0.013 1.326 1.247 N 14 B B CZ NH1 ARG ARG 22 22 -0.083 0.013 1.326 1.243 N 16 B B CZ NH1 ARG ARG 22 22 -0.079 0.013 1.326 1.247 N 18 B B CZ NH1 ARG ARG 22 22 -0.081 0.013 1.326 1.245 N 18 B B CZ NH2 ARG ARG 22 22 -0.080 0.013 1.326 1.246 N 19 B B CZ NH1 ARG ARG 22 22 -0.084 0.013 1.326 1.242 N 20 B B CZ NH1 ARG ARG 22 22 -0.085 0.013 1.326 1.241 N 20 B B CZ NH2 ARG ARG 22 22 -0.086 0.013 1.326 1.240 N 1 A VAL 3 -24.82 -98.35 1 A GLU 4 -71.54 33.86 1 A GLN 5 -138.40 -40.41 1 A CYS 7 -107.14 -64.46 1 A THR 8 -99.57 58.69 1 A SER 9 146.65 -175.84 1 A CYS 11 -150.78 3.54 1 A LEU 13 105.72 -52.55 1 A LEU 16 -18.99 -52.08 1 A ASN 18 -37.01 -21.54 1 B VAL 2 -42.04 62.13 1 B ASN 3 -58.50 23.25 1 B GLN 4 -119.02 -132.47 1 B PHE 24 96.63 61.35 1 B TYR 26 -73.65 46.62 1 B PRO 28 4.56 53.79 2 A ILE 2 45.05 -71.12 2 A VAL 3 -50.63 -77.05 2 A GLN 5 119.92 -46.47 2 A THR 8 -110.01 -88.19 2 A ILE 10 1.64 131.25 2 A CYS 11 -117.12 -157.20 2 A ASN 18 -35.27 -34.93 2 B ASN 3 -142.44 -84.00 2 B GLN 4 115.26 162.60 2 B HIS 5 -34.54 71.40 2 B CYS 19 -5.90 29.93 2 B ARG 22 -28.13 87.81 2 B PHE 24 117.30 76.96 2 B PRO 28 -19.00 -64.72 2 B LYS 29 27.84 78.68 3 A ILE 2 11.34 21.52 3 A VAL 3 -88.17 -120.55 3 A GLU 4 -65.64 71.08 3 A GLN 5 -175.93 -38.10 3 A THR 8 143.97 98.53 3 A SER 9 114.27 -162.77 3 A CYS 11 -57.59 91.03 3 A SER 12 -37.49 174.27 3 B GLN 4 -6.83 61.98 3 B HIS 5 -109.38 66.18 3 B CYS 7 -112.25 70.63 3 B LEU 15 -83.72 31.39 3 B TYR 16 -123.52 -51.26 3 B ARG 22 -100.89 -164.96 3 B PHE 24 64.50 96.64 3 B THR 27 134.87 -66.55 3 B PRO 28 7.99 46.31 3 B LYS 29 -134.45 -46.14 4 A ILE 2 71.92 -68.04 4 A VAL 3 -4.96 -112.93 4 A GLU 4 -55.27 11.60 4 A THR 8 -134.42 -44.29 4 A SER 9 -108.85 -137.28 4 A SER 12 -109.61 -135.30 4 A LEU 13 -21.45 -55.71 4 A GLN 15 -93.28 30.77 4 A ASN 18 -43.98 -17.87 4 B ASN 3 -131.70 -41.02 4 B GLN 4 42.45 -58.53 4 B CYS 19 -8.06 62.30 4 B GLU 21 61.27 75.08 4 B ARG 22 -15.92 72.68 4 B TYR 26 17.72 -70.02 4 B THR 27 16.37 -101.39 4 B PRO 28 1.27 64.94 5 A ILE 2 59.79 -39.57 5 A VAL 3 -85.55 -85.23 5 A THR 8 -143.21 -48.76 5 A SER 9 -120.20 -156.38 5 A SER 12 -29.10 75.30 5 A LEU 13 86.02 -51.20 5 A LEU 16 -130.48 -48.89 5 A ASN 18 -35.17 -37.32 5 B VAL 2 -52.46 75.29 5 B GLN 4 93.52 172.55 5 B HIS 5 -120.07 -164.71 5 B LEU 15 -58.34 -4.12 5 B GLU 21 22.11 51.50 5 B ARG 22 -78.67 -162.23 5 B PHE 24 122.10 63.78 5 B TYR 26 -41.67 -169.71 5 B THR 27 30.54 154.84 5 B PRO 28 -22.19 -36.54 5 B LYS 29 16.54 -50.05 6 A ILE 2 72.90 -69.32 6 A VAL 3 -5.74 -126.19 6 A GLU 4 -21.70 -62.83 6 A SER 9 -122.23 -153.55 6 A CYS 11 -131.85 -156.55 6 A ASN 18 -39.21 -23.39 6 B VAL 2 -120.55 -163.50 6 B ASN 3 -52.65 82.48 6 B HIS 5 -119.59 51.88 6 B CYS 7 -134.53 -53.51 6 B LEU 11 163.81 -63.24 6 B TYR 26 3.83 -75.12 6 B THR 27 85.95 -81.40 6 B PRO 28 8.70 67.43 7 A ILE 2 144.12 -46.90 7 A VAL 3 -45.59 -70.88 7 A THR 8 -156.66 -52.49 7 A SER 9 -108.69 -148.28 7 A CYS 20 -98.81 -128.01 7 B HIS 5 -44.48 65.71 7 B CYS 19 -9.66 60.50 7 B ARG 22 -26.26 50.94 7 B PHE 24 13.77 103.03 7 B TYR 26 -2.64 59.75 7 B PRO 28 -7.19 84.32 7 B LYS 29 -118.25 61.73 8 A VAL 3 -2.78 -111.50 8 A THR 8 -109.43 -75.70 8 A ILE 10 -1.09 103.08 8 A SER 12 -43.29 158.81 8 A ASN 18 -35.10 -28.19 8 B VAL 2 -50.52 70.05 8 B GLN 4 -128.82 -131.85 8 B CYS 19 -3.70 49.57 8 B ARG 22 -28.18 75.71 8 B PHE 25 -51.08 69.99 8 B TYR 26 -69.44 58.78 8 B PRO 28 17.58 68.48 9 A VAL 3 -23.82 -78.76 9 A GLU 4 -72.93 20.50 9 A GLN 5 -120.00 -61.12 9 A THR 8 -154.41 -60.37 9 A ILE 10 8.41 97.04 9 A GLU 17 -68.53 6.59 9 A CYS 20 -66.44 87.12 9 B ASN 3 -123.54 -53.01 9 B GLN 4 49.65 -65.56 9 B GLU 13 -57.53 2.52 9 B LEU 15 -26.00 -65.96 9 B TYR 16 -38.49 -38.12 9 B VAL 18 -35.11 -78.48 9 B GLU 21 71.22 71.63 9 B PHE 24 -6.30 105.11 9 B PHE 25 -66.85 69.12 9 B PRO 28 -76.65 23.67 9 B LYS 29 -12.09 54.23 10 A ILE 2 127.51 -60.74 10 A GLU 4 -55.24 2.18 10 A THR 8 -152.06 -61.65 10 A SER 9 -106.91 74.03 10 A ILE 10 3.02 78.38 10 A LEU 13 126.87 -65.97 10 A ASN 18 -35.51 -26.33 10 B ASN 3 125.56 -32.93 10 B GLN 4 30.59 37.91 10 B CYS 7 -109.04 -62.98 10 B HIS 10 -42.21 -19.27 10 B CYS 19 -78.65 23.90 10 B GLU 21 -131.54 -58.95 10 B PHE 24 85.67 108.38 10 B TYR 26 -0.40 131.50 10 B THR 27 -24.49 -90.29 10 B PRO 28 25.50 -55.73 10 B LYS 29 -14.89 -45.82 11 A ILE 2 40.98 -72.41 11 A VAL 3 -33.26 -71.90 11 A THR 8 -139.27 -46.29 11 A SER 9 -114.02 -148.97 11 A SER 12 -40.20 54.91 11 A LEU 13 83.65 -49.04 11 A LEU 16 -126.26 -53.36 11 A ASN 18 -39.40 -29.92 11 A CYS 20 -98.54 44.51 11 B VAL 2 -90.47 -156.49 11 B ASN 3 99.88 52.44 11 B GLN 4 -59.91 86.70 11 B HIS 5 -42.04 170.83 11 B CYS 19 -42.78 67.25 11 B ARG 22 -31.03 166.58 11 B PHE 24 96.61 142.33 11 B PHE 25 -107.06 44.17 11 B TYR 26 -59.77 96.66 11 B PRO 28 1.61 -58.85 11 B LYS 29 -3.14 63.57 12 A ILE 2 -26.73 -63.17 12 A VAL 3 -36.00 -101.77 12 A GLU 4 -29.52 -21.88 12 A ILE 10 6.72 120.20 12 A ASN 18 -39.40 -28.34 12 B ASN 3 26.93 82.07 12 B GLN 4 -125.01 -156.00 12 B HIS 5 -108.11 77.43 12 B ALA 14 -93.04 -60.55 12 B PHE 24 7.93 156.43 12 B TYR 26 -41.93 81.16 12 B PRO 28 -16.16 -56.27 12 B LYS 29 -2.21 89.92 13 A GLU 4 30.16 -109.62 13 A GLN 5 -24.52 -30.64 13 A SER 9 9.50 37.08 13 A ILE 10 -8.84 147.23 13 A CYS 11 -127.89 -166.69 13 B ASN 3 84.42 -33.62 13 B GLN 4 -23.76 56.76 13 B HIS 5 -66.61 72.61 13 B PHE 24 -4.29 104.69 13 B THR 27 -111.86 -95.37 13 B PRO 28 2.24 53.17 14 A THR 8 -157.28 -48.10 14 A SER 9 -108.57 -128.14 14 A ILE 10 -130.17 -59.35 14 A CYS 11 56.31 128.71 14 A ASN 18 -39.55 -31.02 14 B ASN 3 -38.17 69.28 14 B PHE 24 157.72 154.32 14 B PHE 25 -115.56 71.37 14 B PRO 28 -105.72 40.04 14 B LYS 29 -3.19 52.93 15 A SER 9 -112.31 -148.62 15 A CYS 20 -58.89 16.22 15 B VAL 2 -105.28 -151.62 15 B ASN 3 110.94 49.30 15 B GLN 4 -158.33 -151.63 15 B CYS 7 -129.70 -56.51 15 B HIS 10 -48.17 -12.03 15 B GLU 13 -37.03 -34.28 15 B TYR 16 -27.16 -52.25 15 B CYS 19 -38.59 63.61 15 B GLU 21 38.81 36.78 15 B PHE 24 119.31 77.72 15 B PRO 28 15.10 56.26 16 A ILE 2 78.20 -64.34 16 A VAL 3 -26.17 162.19 16 A GLU 4 43.15 -7.30 16 A GLN 5 -127.19 -52.53 16 A CYS 7 -136.66 -30.10 16 A THR 8 -134.15 -62.33 16 A ILE 10 2.22 84.79 16 A LEU 13 110.79 -56.02 16 A ASN 18 -36.39 -33.47 16 A CYS 20 -112.50 67.20 16 B VAL 2 -37.28 78.21 16 B ASN 3 -5.44 49.77 16 B GLN 4 2.13 -50.29 16 B CYS 7 19.44 164.51 16 B CYS 19 -129.39 -135.90 16 B GLU 21 -76.86 27.62 16 B ARG 22 -62.60 25.27 16 B PHE 24 41.22 72.12 16 B PHE 25 -52.88 73.89 16 B THR 27 7.88 95.32 16 B PRO 28 -97.42 50.11 17 A VAL 3 -4.26 -126.27 17 A GLU 4 -27.56 -72.84 17 A SER 9 -120.14 -161.42 17 A SER 12 -44.33 90.12 17 A LEU 13 116.62 -43.94 17 B VAL 2 -119.95 64.63 17 B HIS 5 -110.19 68.58 17 B TYR 16 -27.80 -44.27 17 B CYS 19 -42.64 67.77 17 B ARG 22 -24.50 63.98 17 B PHE 24 11.46 77.06 17 B THR 27 -96.60 48.96 17 B PRO 28 4.33 38.64 18 A ILE 2 -131.47 -59.51 18 A GLU 4 -107.43 -78.93 18 A GLN 5 -46.97 -18.74 18 A THR 8 173.30 48.39 18 A SER 9 140.36 -160.55 18 A SER 12 -109.49 -160.85 18 A CYS 20 -112.12 69.97 18 B GLN 4 5.44 -89.40 18 B CYS 7 -128.32 -55.56 18 B LEU 11 168.42 -59.22 18 B PHE 24 10.12 166.80 18 B THR 27 -11.16 -118.93 18 B LYS 29 -131.63 -47.93 19 A ILE 2 103.49 145.78 19 A VAL 3 28.66 -150.09 19 A GLU 4 -65.35 19.06 19 A CYS 7 -114.91 51.71 19 A THR 8 136.26 62.00 19 A SER 9 138.61 -170.52 19 B ASN 3 -3.34 -58.36 19 B GLN 4 104.00 -104.35 19 B HIS 5 -117.31 71.66 19 B HIS 10 -59.72 1.96 19 B GLU 21 84.55 0.78 19 B ARG 22 -108.36 -127.26 19 B PHE 24 -68.83 66.19 19 B PHE 25 -92.07 56.49 19 B TYR 26 -21.65 -20.06 19 B THR 27 -12.73 -71.32 19 B PRO 28 23.74 -69.14 19 B LYS 29 0.47 -51.54 20 A ILE 2 -0.53 48.21 20 A VAL 3 -38.20 -114.24 20 A GLN 5 170.38 -49.61 20 A SER 9 110.49 38.66 20 A ILE 10 -3.79 105.89 20 A SER 12 -41.16 176.50 20 A CYS 20 -118.37 79.59 20 B ASN 3 176.63 -37.79 20 B GLN 4 -115.69 -146.68 20 B LEU 17 -123.02 -53.41 20 B VAL 18 -52.34 -71.29 20 B CYS 19 -26.03 -63.37 20 B ARG 22 -124.71 -90.05 20 B PHE 24 61.31 69.61 20 B TYR 26 36.51 114.14 20 B PRO 28 -9.56 58.93 20 B LYS 29 135.28 -20.10 INSULIN THREE-DIMENSIONAL SOLUTION STRUCTURE OF AN INSULIN DIMER. A STUDY OF THE B9(ASP) MUTANT OF HUMAN INSULIN USING NUCLEAR MAGNETIC RESONANCE DISTANCE GEOMETRY AND RESTRAINED MOLECULAR DYNAMICS 1 N N 2 N N A ILE 2 A ILE 2 HELX_P ALPHA HELIX A THR 8 A THR 8 1 A1 7 A LEU 13 A LEU 13 HELX_P ALPHA HELIX A CYS 20 A CYS 20 1 A2 8 B GLY 8 B GLY 8 HELX_P ALPHA HELIX B CYS 19 B CYS 19 1 B1 12 disulf 1.930 A CYS 6 A SG CYS 6 1_555 A CYS 11 A SG CYS 11 1_555 disulf 2.141 A CYS 7 A SG CYS 7 1_555 B CYS 7 B SG CYS 7 1_555 disulf 1.976 A CYS 20 A SG CYS 20 1_555 B CYS 19 B SG CYS 19 1_555 HORMONE HORMONE B THR 27 B THR 27 15 B PRO 28 B PRO 28 23.98 INS_HUMAN UNP 1 90 P01308 INS_HUMAN UNP 2 25 P01308 90 110 1MHI 1 21 P01308 A 1 1 21 25 54 1MHI 1 30 P01308 B 2 1 30 2 SER CONFLICT ASP 9 1MHI B P01308 UNP 33 9 1 P 1